Guangdong Taienkang Pharmaceutical Co. Ltd (301263) — Capital Reinvestment Ratio
Guangdong Taienkang Pharmaceutical Co. Ltd (301263) has a Capital Reinvestment Ratio of 0.77x as of December 2024, meaning it reinvests 1% of its operating cash flow (CN¥89.33 Million) in capital expenditures (CN¥68.55 Million). See net asset quality index of Guangdong Taienkang Pharmaceutical Co. L to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Guangdong Taienkang Pharmaceutical Co. Ltd Capital Reinvestment Ratio (2019–2024)
This chart tracks Guangdong Taienkang Pharmaceutical Co. Ltd's Capital Reinvestment Ratio across 6 annual periods. Check total reinvestment intensity of Guangdong Taienkang Pharmaceutical Co. L to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Guangdong Taienkang Pharmaceutical Co. Ltd (2019–2024)
Year-by-year Capital Reinvestment Ratio for Guangdong Taienkang Pharmaceutical Co. Ltd from 2019 to 2024. For live market cap and broader valuation context, see how much is Guangdong Taienkang Pharmaceutical Co. L worth.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.77x | CN¥89.33 Million | CN¥68.55 Million | ▼ -64.1% |
| 2023 | 2.14x | CN¥93.53 Million | CN¥200.01 Million | ▲ +254.1% |
| 2022 | 0.60x | CN¥148.81 Million | CN¥89.88 Million | ▲ +62.4% |
| 2021 | 0.37x | CN¥120.02 Million | CN¥44.65 Million | ▼ -49.9% |
| 2020 | 0.74x | CN¥125.53 Million | CN¥93.12 Million | ▲ +533.5% |
| 2019 | 0.12x | CN¥75.44 Million | CN¥8.83 Million | — |